b 213 750 (Niacin Extended-Release 750 mg)
Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia; niacin deficiency; pellagra; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for b 213 750
Niacin Extended-Release
- Imprint
- b 213 750
- Strength
- 750 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- Miscellaneous antihyperlipidemic agents, Vitamins
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-7393
More about niacin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 103 Reviews
- Drug class: miscellaneous antihyperlipidemic agents
Consumer resources
- Patient Information
- Niacin (Advanced Reading)
- Niacin Capsules and Tablets
- Niacin Controlled-Release Capsules and Controlled-Release Tablets
- Other brands
- Niaspan, Niacor, Endur-acin, HDL Benefit, ... +5 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.